Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework

Area of Science:

• Dermatology and Transplant Medicine
• Oncology
• Immunology

Background:

• Cutaneous squamous cell carcinoma (CSCC) poses significant morbidity and mortality risks for organ transplant recipients.
• Patients with a history of CSCC have a substantially elevated risk of developing multiple tumors, metastasis, and death compared to the general population.
• Post-transplant CSCC highlights the critical intersection of dermatological and transplant medicine.

Approach:

• Reviewing the necessity of intervention following a first post-transplant CSCC.
• Examining the evidence for secondary prevention strategies, including chemoprevention and immunosuppression modulation.
• Discussing barriers to implementing these interventions and identifying future research directions.

Key Points:

• There is limited consensus on interventions after a first post-transplant CSCC, despite observational data suggesting early treatment is most effective.
• Systemic chemoprevention and immunosuppression modulation are common in patients with multiple CSCC but lack standardized guidelines for first-time diagnoses.
• Prompt, collaborative interventions by dermatology and transplant specialists after a first CSCC are vital for enhancing patient outcomes.

Conclusions:

• Early intervention after a first post-transplant CSCC is critical for secondary prevention of subsequent tumors.
• Further research and collaboration are needed to establish clear guidelines for managing post-transplant CSCC.
• Optimizing treatment strategies can mitigate the increased risk of metastasis and mortality in this vulnerable patient group.